Table. Patient Demographics, Tumor and Treatment Variables, and Local Recurrence.
| Variable | Total No. Patients (n = 334 and 345 Tumors) |
Lost to Follow-up (n = 37 Patients and 39 Tumors) | Recurrence | |
|---|---|---|---|---|
| None (n = 285 Patients and 294 Tumors) | Local (n = 12 Patients and Tumors) | |||
| Demographics | ||||
| Age, mean (SD), y | 67 (13) | 68 (11) | 66 (13) | 70 (10) |
| Male, No. (%) | 235 (70.4) | 22 (59.5) | 204 (71.6) | 9 (75.0) |
| White, No. (%)a | 255 (99) | 24 (100) | 223 (99) | 8 (100) |
| Tumor and Treatment Variables | ||||
| Classification | ||||
| Primary | 340 | 38 | 291 | 11 |
| Recurrent | 5 | 1 | 3 | 1 |
| Tumor site | ||||
| Ear | 39 | 6 | 31 | 2 |
| Lip | 9 | NA | 9 | NA |
| Nose | 52 | 3 | 49 | NA |
| Periocular | 5 | 1 | 4 | NA |
| Other face | 206 | 26 | 173 | 7 |
| Scalp | 16 | 1 | 14 | 1 |
| Neck, trunk, hand/upper extremity | 18 | 2 | 14 | 2 |
| Length of imiquimod therapy, mean (SD), mo | 2.5 (0.5) | 2.5 (0.5) | 2.5 (0.5) | 2.6 (0.5) |
| Length of tazarotene therapy, mean (SD), mo | 2.0 (0.9) | 1.9 (0.9) | 2.0 (0.9) | 2.1 (0.9) |
| Final margin, mean (SD), mm | 3.5 (2.9) | 3.5 (2.9) | 3.4 (2.9) | 4.5 (4.0) |
| Median | 2.0 | 3.0 | 2.0 | 2.5 |
| Stages, mean (SD) | 1.2 (0.5) | 1.1 (0.3) | 1.2 (0.5) | 1.6 (0.6) |
Abbreviation: NA, not applicable.
a
Ethnicity not known for all patients. There were 2 Hispanic patients in the cohort.